文献速递淋巴瘤

T细胞淋巴瘤分子诊断:PCR克隆性评估与靶向NGS的相关性研究

Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS.
PubMed 文献 · Blood Adv · 2021-01-01

该研究将82例T细胞淋巴瘤和25例非肿瘤性T细胞浸润样本分为测试与验证队列,用多重PCR和靶向NGS分别检测TCR基因重排和体细胞突变。突变检测特异性(100.0%)高于T细胞克隆性评估(41.7%-45.5%),敏感性无差异(95.1%-97.4%);t-NGS对部分降解DNA样本仍可评估,且PCR可补充部分t-NGS阴性病例,两者互补。

要点

  • t-NGS检测突变特异性达100.0%,高于PCR克隆性评估的41.7%-45.5%。
  • 两种方法敏感性相近(95.1%-97.4%),无显著差异。
  • t-NGS可评估PCR无法检测的部分降解DNA样本,PCR可补充t-NGS阴性病例。

核心结论

  • t-NGS检测突变比PCR克隆性评估特异性更高,敏感性无差异。
  • t-NGS对部分降解DNA样本可提供可靠诊断依据。
  • PCR与t-NGS互补,PCR可回收部分t-NGS阴性病例。

研究设计与样本

  • 研究纳入82例T细胞淋巴瘤样本和25例非肿瘤性T细胞浸润,分为测试和验证2个队列。
  • 所有样本均用多重PCR和靶向NGS分别检测TCR基因重排和体细胞突变。

主要发现

  • 突变检测特异性为100.0%,T细胞克隆性评估特异性为41.7%-45.5%。
  • 两种方法敏感性为95.1%-97.4%,无差异。
  • t-NGS在部分降解DNA样本中可评估,而PCR无法评估。
  • PCR可检测到部分t-NGS阴性病例。

临床怎么用

  • 在T细胞淋巴瘤诊断中可考虑t-NGS检测突变以提高特异性。
  • 对降解DNA样本可优先尝试t-NGS。
  • PCR与t-NGS联合使用可互补提高诊断可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunomorphological diagnosis of T-cell lymphoma (TCL) may be challenging, especially on needle biopsies. Multiplex polymerase chain reaction (PCR) assays to assess T-cell receptor (TCR) gene rearrangements are now widely used to detect T-cell clones and provide diagnostic support. However, PCR assays detect only 80% of TCL, and clonal lymphocyte populations may also appear in nonneoplastic conditions. More recently, targeted next-generation sequencing (t-NGS) technologies have been deployed to improve lymphoma classification. To the best of our knowledge, the comparison of these techniques' performance in TCL diagnosis has not been reported yet. In this study, 82 TCL samples and 25 nonneoplastic T-cell infiltrates were divided into 2 cohorts (test and validation) and analyzed with both multiplex PCR and t-NGS to investigate TCR gene rearrangements and somatic mutations, respectively. The detection of mutations appeared to be more specific (100.0%) than T-cell clonality assessment (41.7%-45.5%), whereas no differences were observed in terms of sensitivity (95.1%-97.4%). Furthermore, t-NGS provided a reliable basis for TCL diagnosis in samples with partially degraded DNA that was impossible to assess with PCR. Finally, although multiplex PCR assays appeared to be less specific than t-NGS, both techniques remain complementary, as PCR recovered some t-NGS negative cases.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Syrykh C, Gorez P, Péricart S, et al. Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS. Blood Adv. 2021. PMID: 34607351. doi:10.1182/bloodadvances.2021005249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。